These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 7535736

  • 1. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus.
    Tsai SL, Liaw YF, Yeh CT, Chu CM, Kuo GC.
    Hepatology; 1995 Apr; 21(4):908-12. PubMed ID: 7535736
    [Abstract] [Full Text] [Related]

  • 2. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H.
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [Abstract] [Full Text] [Related]

  • 3. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH.
    Verh Dtsch Ges Pathol; 1995 Dec; 79():186-97. PubMed ID: 8600684
    [Abstract] [Full Text] [Related]

  • 4. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, Esteban R, Guardia J.
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [Abstract] [Full Text] [Related]

  • 5. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.
    Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Bartolomé J, Pardo M, Carreño V.
    J Med Virol; 2007 Mar 01; 79(3):236-41. PubMed ID: 17245725
    [Abstract] [Full Text] [Related]

  • 8. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.
    Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A, Petit MA, Fiaccadori F.
    J Immunol; 1990 Nov 15; 145(10):3442-9. PubMed ID: 2230128
    [Abstract] [Full Text] [Related]

  • 9. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, Kaiser R, Sauerbruch T, Spengler U.
    Hepatology; 1996 Oct 15; 24(4):790-5. PubMed ID: 8855177
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Murugavel KG, Balakrishnan P, Kumarasamy N, Solomon S, Thyagarajan SP.
    J Microbiol Immunol Infect; 2009 Apr 15; 42(2):122-8. PubMed ID: 19597643
    [Abstract] [Full Text] [Related]

  • 11. Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection.
    Guido M, Thung SN, Fattovich G, Cusinato R, Leandro G, Cecchetto A, Cesaro S, Panese P, Rugge M.
    Mod Pathol; 1999 Jun 15; 12(6):599-603. PubMed ID: 10392636
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection.
    Pontisso P, Gerotto M, Ruvoletto MG, Fattovich G, Chemello L, Tisminetzky S, Baralle F, Alberti A.
    J Med Virol; 1996 Feb 15; 48(2):157-60. PubMed ID: 8835349
    [Abstract] [Full Text] [Related]

  • 13. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
    Pfeffel F, Oesterreicher C, Penner E, Ferenci P, Sillaber C, Fiedler R, Müller C.
    Wien Klin Wochenschr; 1997 Jan 17; 109(1):20-4. PubMed ID: 9037744
    [Abstract] [Full Text] [Related]

  • 14. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
    Liaw YF, Tsai SL, Sheen IS, Chao M, Yeh CT, Hsieh SY, Chu CM.
    Am J Gastroenterol; 1998 Mar 17; 93(3):354-9. PubMed ID: 9517639
    [Abstract] [Full Text] [Related]

  • 15. Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-gamma production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity.
    Niigaki M, Fukuda R, Hamamoto S, Ishimura N, Ishihara S, Akagi S, Watanabe M, Kinoshita Y.
    Am J Gastroenterol; 2000 Jan 17; 95(1):239-47. PubMed ID: 10638591
    [Abstract] [Full Text] [Related]

  • 16. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases.
    Georgiadou SP, Zachou K, Rigopoulou E, Liaskos C, Mina P, Gerovasilis F, Makri E, Dalekos GN.
    J Viral Hepat; 2004 Jul 17; 11(4):358-65. PubMed ID: 15230859
    [Abstract] [Full Text] [Related]

  • 17. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
    Chu CM, Sheen IS, Liaw YF.
    Scand J Gastroenterol; 2004 Aug 17; 39(8):778-82. PubMed ID: 15513365
    [Abstract] [Full Text] [Related]

  • 18. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.
    Transplant Proc; 2005 Sep 17; 37(7):3045-7. PubMed ID: 16213299
    [Abstract] [Full Text] [Related]

  • 19. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.
    Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A, Onofrio M, Scolastico C, Filippini P.
    Hepatology; 2002 Nov 17; 36(5):1285-91. PubMed ID: 12395342
    [Abstract] [Full Text] [Related]

  • 20. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?
    Huo TI, Huang YH, Hsia CY, Su CW, Lin HC, Hsu CY, Lee PC, Lui WY, Loong CC, Chiang JH, Chiou YY, Lee SD.
    Liver Int; 2009 May 17; 29(5):767-73. PubMed ID: 19018974
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.